121 related articles for article (PubMed ID: 1491735)
1. Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease.
Schegg KM; Harrington LS; Neilsen S; Zweig RM; Peacock JH
Neurobiol Aging; 1992; 13(6):697-704. PubMed ID: 1491735
[TBL] [Abstract][Full Text] [Related]
2. Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain.
Schegg KM; Nielsen S; Zweig RM; Peacock JH
Prog Clin Biol Res; 1989; 317():437-52. PubMed ID: 2602428
[TBL] [Abstract][Full Text] [Related]
3. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
Arendt T; Brückner MK; Lange M; Bigl V
Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type.
Fishman EB; Siek GC; MacCallum RD; Bird ED; Volicer L; Marquis JK
Ann Neurol; 1986 Mar; 19(3):246-52. PubMed ID: 3963769
[TBL] [Abstract][Full Text] [Related]
5. Molecular forms of acetylcholinesterases in Alzheimer's disease.
Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
[TBL] [Abstract][Full Text] [Related]
6. Changes in membrane-bound and soluble molecular forms of acetylcholinesterase in mouse hippocampus after cholinergic denervation.
Schegg KM; Gillespie RP; Prym U; Peacock JH
Neurosci Lett; 1990 Oct; 118(2):197-200. PubMed ID: 2274269
[TBL] [Abstract][Full Text] [Related]
7. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
J Neurochem; 1986 Jul; 47(1):263-77. PubMed ID: 3711902
[TBL] [Abstract][Full Text] [Related]
8. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.
Siek GC; Katz LS; Fishman EB; Korosi TS; Marquis JK
Biol Psychiatry; 1990 Mar; 27(6):573-80. PubMed ID: 2322617
[TBL] [Abstract][Full Text] [Related]
9. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
[TBL] [Abstract][Full Text] [Related]
10. VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type.
Danielsson E; Eckernäs SA; Westlind-Danielsson A; Nordström O; Bartfai T; Gottfries CG; Wallin A
Neurobiol Aging; 1988; 9(2):153-62. PubMed ID: 2897639
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain.
Ogane N; Giacobini E; Struble R
Brain Res; 1992 Sep; 589(2):307-12. PubMed ID: 1393597
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.
Henke H; Lang W
Brain Res; 1983 May; 267(2):281-91. PubMed ID: 6871677
[TBL] [Abstract][Full Text] [Related]
13. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging.
DeKosky ST; Scheff SW; Markesbery WR
Neurology; 1985 Oct; 35(10):1425-31. PubMed ID: 4033925
[TBL] [Abstract][Full Text] [Related]
14. Size and charge isomers of acetylcholinesterase in the cerebral cortex of young and aged rats.
Bisso GM; Briancesco R; Michalek H
Neurochem Res; 1991 May; 16(5):571-5. PubMed ID: 1754033
[TBL] [Abstract][Full Text] [Related]
15. Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization.
Nakamura S; Kawashima S; Nakano S; Tsuji T; Araki W
J Neural Transm Suppl; 1990; 30():13-23. PubMed ID: 2391513
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.
Nakano S; Kato T; Nakamura S; Kameyama M
J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912
[TBL] [Abstract][Full Text] [Related]
17. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Rakonczay Z
Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
19. Bilateral symmetry of cholinergic deficits in Alzheimer's disease.
Zubenko GS; Moossy J; Hanin I; Martinez AJ; Rao GR; Kopp U
Arch Neurol; 1988 Mar; 45(3):255-9. PubMed ID: 3341949
[TBL] [Abstract][Full Text] [Related]
20. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
Sorbi S; Antuono P; Amaducci L
Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
